Nonalcoholic liver cirrhosis. Fibrosis and cirrhosis of liver
Conditions
Interventions
Intervention group: The status of knowledge patients from their disease was assessed and graded based on a questionnaire. The quality of life of patients was evaluated and graded based on quality of l
Sponsors
Vice Chancellor for Research and Technology of Ahvaz Jundishapur University of Medical
Eligibility
Sex/Gender
All
Age
18 Years to No maximum
Inclusion criteria
Inclusion criteria: The desire to participate in the study Age over 18 years Patients with non-alcoholic liver cirrhosis from different stages of the Child Score
Exclusion criteria
Exclusion criteria: The presence of medical conditions and concomitant illnesses, such as cardiopulmonary disease or uncontrolled kidney disease The presence of any kind of cancer, such as hepatocellular cancers Pregnancy Lack of referral after 6 months of intervention
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Awareness level. Timepoint: Before and after the intervention. Method of measurement: Through the questionnaire.;Quality of Life. Timepoint: Before and after the intervention. Method of measurement: Through the chronic liver disease questionnaire.;Illness severity. Timepoint: Before and after the intervention. Method of measurement: Through the MELD scoring system.;Frequency of hospitalization. Timepoint: It was evaluated over a period of 6 months and compared with 6 months prior to notification and nutritional monitoring of patients. Method of measurement: Based on patient records.;Gastrointestinal bleeding. Timepoint: It was evaluated over a period of 6 months and compared with 6 months prior to notification and nutritional monitoring of patients. Method of measurement: Based on patient records.;Ascetic. Timepoint: It was evaluated over a period of 6 months and compared with 6 months prior to notification and nutritional monitoring of patients. Method of measurement: Based on patient records.;Hepatic encephalopathy. Timepoint: It was evaluated over a period of 6 months and compared with 6 months prior to notification and nutritional monitoring of patients. Method of measurement: Based on patient records. | — |
Secondary
| Measure | Time frame |
|---|---|
| Body mass index. Timepoint: Before and after the intervention. Method of measurement: The value was derived from the weight (kilogram) and height (meter) of an individual and the unit was kg/m2.;Blood urea nitrogen (BUN). Timepoint: Before and six months after intervention. Method of measurement: laboratory test.;Blood creatinine. Timepoint: Before and six months after intervention. Method of measurement: laboratory test.;Blood sodium. Timepoint: Before and six months after intervention. Method of measurement: laboratory test.;Blood potassium. Timepoint: Before and six months after intervention. Method of measurement: laboratory test.;Alanine Aminotransferase. Timepoint: Before and six months after intervention. Method of measurement: laboratory test.;Aspartate Aminotransferase. Timepoint: Before and six months after intervention. Method of measurement: laboratory test.;Alkaline phosphatase. Timepoint: Before and six months after intervention. Method of measurement: laboratory test.;Alpha-fetoprotein. Timepoint: Before and six months after intervention. Method of measurement: laboratory test.;Total bilirubin. Timepoint: Before and six months after intervention. Method of measurement: laboratory test.;Direct bilirubin. Timepoint: Before and six months after intervention. Method of measurement: laboratory test.;International normalized ratio (INR). Timepoint: Before and six months after intervention. Method of measurement: laboratory test.;Thyroid-stimulating hormone. Timepoint: Before and six months after intervention. Method of measurement: laboratory test. | — |
Countries
Iran (Islamic Republic of)
Contacts
Public ContactBaharak Danyaee
Ahvaz University of Medical Sciences
Outcome results
None listed